Statin-induced anti-HMGCR antibody-related immune-mediated necrotising myositis achieving complete remission with rituximab

Statin-induced immune-mediated necrotising myopathy (IMNM) is a rare but increasingly recognised myositis. Many cases have positive antibodies to 3-hydroxy-3-methylglutaryl coenzyme A reductase (anti-HMGCR). The current treatment is ceasing the statin, but often immunosuppressive therapy is required...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMJ Case Rep
Päätekijät: Zhang, Wenwen, Prince, Henry Miles, Reardon, Katrina
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2019
Aiheet:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6887445/
https://ncbi.nlm.nih.gov/pubmed/31791994
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-232406
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia